Computational structural analyses predict that the SARS-CoV-2 RBD-human-ACE2 interaction is ‘not ideal’ and that its RBD sequence differs from the residues shown in SARS-CoV to be optimal for receptor binding, despite the virus binding hACE2 with high affinity in practice.